Fem Osteo HRT®  ( 60 or 180 tablets ) Product # FE017-meta (180)     SIX TABLETS SUPPLY:       Microcrystalline Hydroxyapatite Concentrate (MCHC)†  3361 mg     Calcium (as MCHC and dicalcium phosphate) 1515 mg     Phosphorus (as MCHC and dicalcium phosphate)  975 mg     Vitamin A (100% as beta-carotene††)  25000 IU     Vitamin E (as d-alpha tocopheryl succinate) 400 IU     Vitamin D (as cholecalciferol) 400 IU     Vitamin C (as Ultra Potent-C®†††) 300 mg     Magnesium (as magnesium bis-glycinate*) 200 mg     Niacin (as niacinamide and niacinamide ascorbate) 200 mg     Pantothenic Acid (as D-calcium pantothenate)  150 mg     Vitamin B6 (as pyridoxine hydrochloride) 50 mg     Riboflavin 17 mg     Thiamin (as thiamin mononitrate) 15 mg     Zinc (as zinc glycinate**) 15 mg     Copper (as copper glycinate**) 2 mg     Manganese (as manganes glycinate**)  250 mcg     Folate (as folic acid) 800 mcg     Quercetin (as quercetin dihydrate)  42 mg     Alpha-Carotene 270 mcg     Cryptoxanthin 77 mcg     Zeaxanthin 39 mcg     Lutein 39 mcg       Suggested Use:As a dietary supplement, six tablets daily, or as directed by health practitioner   † Microcrystalline hydroxyapatite concentrate contains calcium, phosphorus, and trace quantities of other minerals. †† From Caro-xan™, a proprietary blend of beta-carotene and Betatene® mixed carotenoids. ††† Ultra Potent-C® is a patented form of vitamin C: U.S. Patent #5,626,883. For a list of ingredients, please refer to the Ultra Potent-C product description. * As MetaMag™, our proprietary fully reacted magnesium amino acid chelate: U.S. Patent Nos. 4,830,716; 4,599,152 Albion®. ** Patented mineral amino acid chelates: U.S. Patent Nos. 4,830,716; 4,599,152 Albion®. Fem Osteo HRT® is a trademark of Metagenics, Inc. and is used by permission.